Fluvastatin in the Therapy of Acute Coronary Syndrome

Fluvastatin in the Therapy of Acute Coronary Syndrome

This study is to evaluate the safety and efficacy of fluvastatin versus placebo, dosed shortly after or immediately when the coronary event occurs.

Inclusion Criteria:

• Acute coronary syndrome
• Adults, 18 years and older

Exclusion Criteria:

• History of lipid lowering therapy less than 30 days before index event
• Pregnancy and nursing
• Subject younger than 18 years

Other inclusion and exclusion criteria may apply.